UNSPSC 51292011: Fluoxetine

This classification denotes a selective serotonin reuptake inhibitor and antidepressant agent with the molecular formula C17H18F3NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 01K63SUP8D, chemically known as (+) or (-)-n-methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-p-tolyl)oxy)propylamine but generally known as fluoxetine, which bears US NIH Compound Identifier 3386. European Medicines Agency schedules Fluoxetine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07723MIG.

UNSPSC 51292011 Fluoxetine is a Commodity code that nominally covers a specific pharmaceutical product, yet the single recent state and local opportunity posted under this code is plainly misaligned with its scope. Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking to procure naloxone and safe drug deactivation systems—neither of which are fluoxetine—through a competitive sealed-bid process with quarterly deliveries to the Seminole County Community Health Building. The mismatch suggests either a coding error in the source data or a county procurement office's use of an imprecise taxonomy assignment. The opportunity itself reflects genuine public-health demand: naloxone for overdose reversal and drug deactivation systems for safe disposal support community health initiatives, but these products fall outside the fluoxetine code's intended scope.

The single record does not support a characterization of issuing-body concentration or geographic spread for this code. Seminole County's June 2026 posting (with a July 26, 2023 due date in the record) is the only recent opportunity visible, and it does not match the code's definition. State and local procurement activity under UNSPSC 51292011 Fluoxetine does not show sufficient recent volume or relevant scope to evaluate as an active market segment for fluoxetine itself.